✦ LIBER ✦

Gene Expression Profiling Reveals Unique Molecular Subtypes of Neurofibromatosis Type I-associated and Sporadic Malignant Peripheral Nerve Sheath Tumors

✍ Scribed by Mark A. Watson; Arie Perry; Tarik Tihan; Richard A. Prayson; Abhijit Guha; Julia Bridge; Rosalie Ferner; David H. Gutmann

Book ID: 111404273
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 684 KB
Volume: 14
Category: Article
ISSN: 1015-6305
DOI: 10.1111/j.1750-3639.2004.tb00067.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current status of sporadic and neurofibr

Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

✍ Brigitte C. Widemann 📂 Article 📅 2009 🏛 Current Science Inc. 🌐 English ⚖ 326 KB

Computer-assisted cytogenetic analysis o

Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: Sporadic Vs. neurofibromatosis-type-1-associated malignant schwannomas

✍ Boudewijn E.C. Plaat; Willemina M. Molenaar; Mirjam F. Mastik; Harald J. Hoekstr 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB 👁 1 views

Cytogenetic studies in small groups of patients with malignant peripheral-nerve-sheath tumors (MPNST) revealed complex karyotypes with no consistent changes. A computerassisted cytogenetic analysis using a cytogenetic database was performed to determine recurrent cytogenetic alterations in 51 MPNSTs

Microarray-based copy number analysis of

Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho–GTPase pathway genes in NF1 tumorigenesis

✍ Meena Upadhyaya; Gill Spurlock; Laura Thomas; Nick S. T. Thomas; Mark Richards; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

Neurofibromatosis type-1 (NF1) is associated with the growth of benign and malignant tumors. Approximately 15% of NF1 patients develop malignant peripheral nerve sheath tumors (MPNSTs), underlining the need to identify specific diagnostic/prognostic biomarkers associated with MPNST development. The